Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Microtubule Inhibition [PE]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
PACLITAXEL 77,334 12,030 15.6% 31,638 6,087 60.3 yrs 69.4%
DOCETAXEL 64,992 6,068 9.3% 13,463 2,519 56.0 yrs 83.4%
BRENTUXIMAB VEDOTIN 9,724 1,922 19.8% 3,781 696 49.7 yrs 41.6%
ERIBULIN 5,055 793 15.7% 2,642 238 57.3 yrs 93.0%
DOCETAXEL ANHYDROUS 1,084 5 0.5% 10 1 55.6 yrs 99.2%
TIRBANIBULIN 197 0 N/A 3 0 62.7 yrs 57.9%
GRISEOFULVIN 132 4 3.0% 53 3 35.3 yrs 40.0%

Head-to-Head Comparisons

PACLITAXEL vs DOCETAXEL PACLITAXEL vs BRENTUXIMAB VEDOTIN PACLITAXEL vs ERIBULIN PACLITAXEL vs DOCETAXEL ANHYDROUS DOCETAXEL vs BRENTUXIMAB VEDOTIN DOCETAXEL vs ERIBULIN DOCETAXEL vs DOCETAXEL ANHYDROUS BRENTUXIMAB VEDOTIN vs ERIBULIN BRENTUXIMAB VEDOTIN vs DOCETAXEL ANHYDROUS ERIBULIN vs DOCETAXEL ANHYDROUS
← Back to Microtubule Inhibition [PE] Class side effects →